NIVESTIM 12 MU/0.2 ml, solution for injection/for infusion syringe, 0.2 ml
Active ingredients: Filgrastim
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection or infusionsyringe, 0.2 mlintraveineuse;sous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- NIVESTIM 12 MU/0,2 ml, solution injectable/pour perfusion
- Pharmaceutical form
- solution injectable ou pour perfusion
- Route of administration
- intraveineuse;sous-cutanée
- Presentation description
- 1 seringue(s) préremplie(s) en verre de 0,2 ml avec aiguille(s) sécurisée(s)
- Marketing authorisation holder
- PFIZER EUROPE MA EEIG (BELGIQUE)
- Reimbursement according to BDPM
- 100%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 29 Aug 2011
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65387858CIP74941337CIP133400949413379Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| FILGRASTIMsolution | 120 microgrammes · 0,2 ml de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.